Abstract
The aim of this paper was to investigate the effects of resistin on human umbilical vein endothelial cells (HUVECs), and to explore its role and mechanism of action in atherosclerosis. HUVECs were incubated with recombinant human resistin (0, 50, 100 ng/mL) for 24 h. ICAM-1, VCAM-1 and reactive oxygen species (ROS) were assayed by flow cytometer. ET-1, eNOS and iNOS mRNA expression were measured by semi-quantitative RT-PCR. Incubation of HUVECs with resistin resulted in an increase in ICAM-1 expression and ET-1 mRNA expression. However, resistin had no effect on VCAM-1 expression and ROS release. eNOS and iNOS mRNA expression were not altered by resistin stimulation. Adipokine resistin exerted a direct effect in promoting HUVEC dysfunction by promoting ICAM-1 and ET-1 expression. These data suggest that adipocyte-endothelium cross-talk might play an important role in the pathogenesis of cardiovascular disease in diabetes mellitus.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Yang R Z, Lee M J, Hu H, Pray J, Wu H B, Hansen B C, Shuldiner A R, Fried S K, McLenithan J C, Gong D W. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab, 2006, 290(6): E1253–E1261
Hug C, Lodish H F. Medicine. Visfatin: a new adipokine. Science, 2005, 307(5708): 366–367
Cooke J P, Oka P K. Does leptin cause vascular disease. Circulation, 2002, 106(15): 1904–1905
Steppan C M, Bailey S T, Bhat S, Brown E J, Banerjee R R, Wright C M, Patel H R, Ahima R S, Lazar M A. The hormone resistin links obesity to diabetes. Nature, 2001, 409(6818): 307–312
Minter A J, Dawes J, Chesterman C N. Effects of heparin and endothelial cell growth supplement on haemostatic functions of vascular endothelium. Thromb Haemost, 1992, 67(6): 718–723
Plutzky J, Viberti G, Haffner S. Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets. J Diabetes Complications, 2002, 16(6): 401–415
Mather K J, Verma S, Anderson T J. Improved endothelial function with metformin in type 2 diabetes mellitus. J Am Coll Cardiol, 2001, 37(5): 1344–1350
Banerjee R R, Rangwala S M, Shapiro J S, Rich A S, Rhoades B, Qi Y, Wang J, Rajala M W, Pocai A, Scherer P E, Steppan C M, Ahima R S, Obici S, Rossetti L, Lazar M A. Regulation of fasted blood glucose by resistin. Science, 2004, 303(5661): 1195–1198
Rangwala S M, Rich A S, Rhoades B, Shapiro J S, Obici S, Rossetti L, Lazar M A. Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes, 2004, 53(8): 1937–1941
Fehmann H C, Heyn J. Plasma resistin levels in patients with type 1 and type 2 diabetes mellitus and in healthy controls. Horm Metab Res, 2002, 34(11–12): 671–673
Kawanami D, Maemura K, Takeda N, Harada T, Nojiri T, Imai Y, Manabe I, Utsunomiya K, Nagai R. Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endithelial cell interactions. Biochem Biophys Res Commun, 2004, 314(2): 415–419
Maeda N, Shimomura I, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med, 2002, 8(7): 731–737
Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, Mori Y, Ide T, Murakami K, Tsuboyama-Kasaoka N, Ezaki O, Akanuma Y, Gavrilova O, Vinson C, Reitman ML, Kagechika H, Shudo K, Yoda M, Nakano Y, Tobe K, Nagai R, Kimura S, Tomita M, Froguel P, Kadowaki T. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med, 2001, 7(8): 941–946
Verma S, Li S H, Wang C H, Fedak P W, Li R K, Weisel R D, Mickle D A. Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation, 2003, 108(6): 736–740
Godin C, Caprani A, Dufaux J, Flaud P. Interactions between neutrophils and endothelial cells. J Cell Sci, 1993, 106(Pt2): 441–451
Kougias P, Chai H, Lin P H, Lumsden A B, Yao Q, Chen C. Adipocyte-derived cytokine resistin causes endothelial dysfunction of porcine coronary arteries. J Vasc Surg, 2005, 41(4): 691–698
Montagnani M, Chen H, Barr V A, Quon M J. Insulin-stimulated activation of eNOS is independent of Ca2+ but requires phosphorylation by Akt at Ser (1179). J Biol Chem, 2001, 276(32): 30392–30398
Morrow V A, Foufelle F, Connell J M, Petrie J R, Gould G W, Salt I P. Direct activation of AMP-activated protein kinase stimulates nitric-oxide synthesis in human aortic endothelial cells. J Biol Chem, 2003, 278(34): 31629–31639
Verma S, Li S H, Badiwala M V, Weisel R D, Fedak P W, Li R K, Dhillon B, Mickle D A. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein. Circulation, 2002, 105(6): 1890–1896
Jung H S, Park K H, Cho Y M, Quon M J. Resistin is secreted from macrophages in atheromas and promotes atherosclerosis. Cardiovasc Res, 2006, 69(1): 76–85
Author information
Authors and Affiliations
Additional information
Translated from Journal of Sun Yat-Sen University (Medical Sciences), 2006, 27(3): 258–261 [译自: 中山大学学报 (医学科学版)]
Rights and permissions
About this article
Cite this article
Li, Z., Li, F., Yan, L. et al. Study on the action of resistin-induced human umbilical vein endothelial cell dysfunction. Front. Med. China 1, 196–199 (2007). https://doi.org/10.1007/s11684-007-0037-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11684-007-0037-z